Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer

Cancer Research

Volumn 61, Issue 11, 2001, Pages 4371-4374

  Sood, A K ^a   Holmes, R ^a   Hendrix, M J C ^a   Buller, R E ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; TUMOR MARKER;

ADULT; ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; DNA DETERMINATION; FEMALE; GENE LOCUS; GENETIC LINKAGE; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; MICROSATELLITE REPEATS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 0035360815     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Microsatellite instability in cancer of the proximal colon
2. Genetic mapping of a locus predisposing to human colorectal cancer
3. Clues to the pathogenesis of familial colorectal cancer
4. Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients
5. Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives
6. Microsatellite instability: New aspects in the carcinogenesis of colorectal carcinoma
7. Causes and consequences of microsatellite instability in endometrial carcinoma
8. Microsatellite instability and mutations of p53 and TGF-β RII genes in gastric cancer
9. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
10. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer
11. Genomic instability in ovarian cancer: A reassessment using an arbitrarily primed polymerase chain reaction
12. Microsatellite instability in ovarian carcinoma
13. Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients
14. Microsatellite instability differences between familial and sporadic ovarian cancers
15. Lessons from hereditary colorectal cancer
16. MutS homologues in mammalian cells
17. Immunohistochemistry for hMLH1 and hMSH2: A practical test for DNA mismatch repair-deficient tumors
18. The application of microsatellites in molecular pathology
19. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
20. An abundance of p53 null mutations in ovarian carcinoma
21. Absence of significant germ line p53 mutations in ovarian cancer patients
22. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines
23. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites
24. Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin. Implications for microsatellite instability testing
25. Detection of mutations in mismatch repair genes in Portuguese families with hereditary nonpolyposis colorectal cancer (HNPCC) by a multimethod approach
26. Immunohistochemical analysis of DNA "mismatch-repair" enzyme human Mut-S-Homolog-2 in ovarian carcinomas
27. Diagnostic microsatellite instability: Definition and correlation with mismatch repair protein expression
28. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy
29. Genomic instability in sporadic colorectal cancer quantitated by intersimple sequence repeat PCR analysis
30. Microsatellite instability in ovarian and other pelvic carcinomas
31. Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer
32. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer
33. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer
34. Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival
35. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
36. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
37. p53 gene mutation, microsatellite instability, and adjuvant chemotherapy: Impact on survival of 388 patients with Dukes' C colon carcinoma
38. Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis
39. Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor
40. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas
41. Genetic instability in incidentally discovered and advanced prostate cancer
42. Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer
43. Prognostic significance of microsatellite instability in patients with gastric carcinoma
44. The clinicopathologic features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": A study of the TGFβ RII, IGFII R, and BAX genes
45. Methylation of the promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability
46. Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumors
47. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability